Tuberculosis screening and active tuberculosis among HIV-infected persons in a Canadian tertiary care centre

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 20, Issue 2, 2009, Pages 51-57

  Brassard, Paul ^a,b,c   Hottes, Travis Salway ^b   Lalonde, Richard G ^c   Klein, Marina B ^b,c  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

HIV; Prevention; Risk profile; Screening; Tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEALTH CENTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LIVER FUNCTION TEST; LUPUS LIKE SYNDROME; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYALGIA; RETROSPECTIVE STUDY; SCREENING; SIDE EFFECT; TERTIARY HEALTH CARE; TUBERCULIN TEST; TUBERCULOSIS;

EID: 66949118576     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/658382     Document Type: Article

References (29)

1. Friedland GH, Churchyard GJ, Nardell E. Tuberculosis and HIV coinfection: Current state of knowledge and research priorities. J Infect Dis 2007;196:S1-S3. (Pubitemid 47206078)
2. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-550 (Pubitemid 19070537)
3. Havlir DV, Barnes PF. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1999;340:367-373 (Pubitemid 29090803)
4. Haase I, Olson S, Behr MA, et al. Use of geographic and genotyping tools to characterise tuberculosis transmission in Montréal. Int J Tuberc Lung Dis 2007;11:632-638 (Pubitemid 46868623)
5. Palella FJ Jr, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006;43:27-34. (Pubitemid 44306484)
6. Hanna DB, Gupta LS, Jones LE, Thompson DM, Kellerman SE, Sackoff JE. AIDS-defining opportunistic illnesses in the HAART era in New York City. AIDS Care 2007;19:264-272 (Pubitemid 46269501)
7. Dore GJ, Li Y, McDonald A, Ree H, Kaldor JM. Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia. J Acquir Immune Defic Syndr 2002;29:388-395 (Pubitemid 34288893)
8. Guenther T, Geduld J, Archibald CP. Tuberculosis among AIDS cases in Canada from 1994 to 1999: Analysis of data from the Canadian HIV/AIDS case reporting surveillance system. In: Abstracts of the 10th Annual Canadian Conference on HIV/AIDS Research. Canada: Can J Infect Dis, 2001.
9. Centers for Disease Control and Prevention. Tuberculosis and human immunodeficiency virus infection: Recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). MMWR Morb Mortal Wkly Rep 1989;38:236-8,43-50.
10. Public Health Agency of Canada. Canadian Tuberculosis Standards. 〈http://www.phac-aspc.gc.ca/tbpc-latb/pubs/pdf/tbstand07-e.pdf〉. (Version current at December 1, 2008).
11. Elzi L, Schlegel M, Weber R, et al. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis 2007;44:94-102. (Pubitemid 44968992)
12. Lee LM, Lobato MN, Buskin SE, Morse A, Costa OS. Low adherence to guidelines for preventing TB among persons with newly diagnosed HIV infection, United States. Int J Tuberc Lung Dis 2006;10:209-214 (Pubitemid 43275547)
13. Sackoff JE, Torian LV, Frieden TR, Brudney KF, Menzies IB. Purified protein derivative testing and tuberculosis preventive therapy for HIV-infected patients in New York City. AIDS 1998;12:2017-2023 (Pubitemid 28479278)
14. Schulte JM, Bryan P, Dodds S, Potter M, Onorato IM, O'Sullivan MJ. Tuberculosis skin testing among HIV-infected pregnant women in Miami, 1995 to 1996. J Perinatol 2002;22:159-162
15. Welch KJ, Morse A. Improving tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 2002;165:1452.
16. Kaplan JE, Masur H, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Morb Mortal Wkly Rep 2002;51:1-52.
17. Brassard P, Remis RS. Incidence of tuberculosis among reported AIDS cases in Quebec from 1979 to 1996. CMAJ 1999;160:1838-1842
18. Sahai H, Khurshid A. Statistics in epidemiology: Methods, techniques, and applications. CRC Press; 1996.
19. van Buuren S, Oudshoorn K. Multivariate imputation by chained equations. 〈http://www.multiple-imputation.com〉 (Version current at December 1, 2008).
20. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing, 2006.
21. Hosmer D, Lemeshow S. Applied Logistic Regression, 2nd edn. Wiley-Interscience Publication, 2000.
22. World Health Organization. Global tuberculosis control: Surveillance, planning, financing. 〈http://www.who.int/tb/publications/global-report/en/ 〉 (Version current at December 1, 2008).
23. Public Health Agency of Canada. Tuberculosis in Canada. 〈http://www.phac-aspc.gc.ca/publicat/2007/tbcan03/pdf/tbcan03e.pdf〉 (Version current at December 1, 2008).
24. Kahle E, Zhang Q, Golden M, Goldbaum G, Buskin S. Trends in evaluation for sexually transmitted infections among HIV-infected people, King County, Washington. Sex Transm Dis 2007;34:940-946 (Pubitemid 350158842)
25. Mohle-Boetani JC, Miller B, Halpern M, et al. School-based screening for tuberculous infection. A cost-benefit analysis. JAMA 1995;274:613-619
26. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Morb Mortal Wkly Rep 2000;49:1-51.
27. Schwartzman K, Menzies D. Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis. Am J Respir Crit Care Med 2000;161:780-789 (Pubitemid 30171731)
28. Centers for Disease Control and Prevention. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: Revised recommendations. MMWR Morb Mortal Wkly Rep 1997;46:1-10.
29. Canadian Tuberculosis Committee. Recommendations for the screening and prevention of tuberculosis in patients with HIV and the screening for HIV in tuberculosis patients and their contacts. Can Commun Dis Rep 2002;28:1-6.